OptimizeRx (OPRX) Enterprise Value: 2010-2025
Historic Enterprise Value for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to -$19.5 million.
- OptimizeRx's Enterprise Value fell 2104.06% to -$19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.5 million, marking a year-over-year decrease of 2104.06%. This contributed to the annual value of -$13.4 million for FY2024, which is 340.75% up from last year.
- OptimizeRx's Enterprise Value amounted to -$19.5 million in Q3 2025, which was down 2104.06% from -$16.6 million recorded in Q2 2025.
- Over the past 5 years, OptimizeRx's Enterprise Value peaked at -$13.4 million during Q4 2024, and registered a low of -$89.0 million during Q1 2022.
- Moreover, its 5-year median value for Enterprise Value was -$63.5 million (2023), whereas its average is -$52.2 million.
- As far as peak fluctuations go, OptimizeRx's Enterprise Value crashed by 70520.66% in 2021, and later skyrocketed by 8131.69% in 2023.
- Over the past 5 years, OptimizeRx's Enterprise Value (Quarter) stood at -$84.7 million in 2021, then rose by 12.45% to -$74.1 million in 2022, then surged by 81.32% to -$13.9 million in 2023, then increased by 3.41% to -$13.4 million in 2024, then plummeted by 45.88% to -$19.5 million in 2025.
- Its Enterprise Value was -$19.5 million in Q3 2025, compared to -$16.6 million in Q2 2025 and -$16.6 million in Q1 2025.